---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-24-000113"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T09:26:56.766894+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stryker Q3 beats: adj EPS $2.87 (+16.7%), sales $5.5B (+11.5% organic), raises FY guidance

## Summary
- Reported net sales $5.5B, +11.9% reported, +11.5% organic; adjusted EPS $2.87, +16.7%.
- Adjusted operating margin expanded 130bps to 24.7%.
- MedSurg & Neurotechnology organic sales +12.7%; Orthopaedics & Spine +9.7%.
- FY2024 guidance raised: organic sales growth 9.5%-10.0%, adjusted EPS $12.00-$12.10.
- CEO cites product innovation and acquisitions as growth drivers.

## SEC filing metadata
- accession: 0000310764-24-000113
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076424000113/0000310764-24-000113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076424000113/syk-20241029.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-24-000113
- JSON: https://secwatch.observer/filing/0000310764-24-000113.json
- Plain text: https://secwatch.observer/filing/0000310764-24-000113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.